Patent · US Active

Anti-OX40 antibodies and uses thereof

US10934365B2 · kind B2 · utility

1Cited by
6References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 22, 2020
Grant dateMar 2, 2021
Priority date—
Expiry dateMay 22, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This disclosure relates to anti-OX40 (TNF Receptor Superfamily Member 4, or TNFRSF4) antibodies, antigen-binding fragments, and the uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.